Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Prevention Trial in Subjects at High Risk for Hormone Non-responsive Breast Cancer

NCT01500577 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT01500577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Prevention Trial in Subjects at High Risk for Hormone Non-responsive Breast Cancer
Lead sponsor
European Institute of Oncology
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
July 31, 2013
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer